| Outcome Measures: |
Primary: Volumetric measurement of the pancreas, A RMN will be done before and 1 year after the treatment. A comparative mesure of pancreatic volume will be performed., 1 year | Secondary: Quantitative response to secretin, A RMN with injection of secretin will be done before and after the treatment. A quantitative evaluation of secretin response will be performed., 1 year | Other: Fasting glycemia, Quarterly during 1 years a blood analysis will be done., 1 year|C-Peptide, Quarterly during 1 year a blood analysis will be done., 1 years|HbA1c, Quarterly during 1 year a blood analysis will be done., 1 year|Cholesterol, Quarterly during 1 year a blood analysis will be done., 1 year|Calcium, Quarterly during 1 year a blood analysis will be done., 1 year|Phosphorus, Quarterly during 1 year a blood analysis will be done., 1 year|Urea, Quarterly during 1 year a blood analysis will be done., 1 year|Creatininemia, Quarterly during 1 year a blood analysis will be done., 1 year|Bilirubinemia, Quarterly during 1 year a blood analysis will be done., 1 year|Alcaline phosphatase, Quarterly during 1 year a blood analysis will be done., 1 year|Gamma GT, Quarterly during 1 year a blood analysis will be done., 1 year|Alanine aminotransferase, Quarterly during 1 year a blood analysis will be done., 1 year|Asparate aminotransferase, Quarterly during 1 year a blood analysis will be done., 1 year|Lipasemia, Quarterly during 1 year a blood analysis will be done., 1 year
|
